Your Blood Tests NEVER Reveal Root-Causes of Your Poor Health.
FrugalDoc says "NEVER" to make the point that modern medicine is GUESSING about WHY you are not healthy.
FrugalDoc
11/17/20267 min read


Image: An Occult Obligate Intracellular invading a cell and its mitochondria to ROB its energy (from YOU!).
The name tells all:
Occult: hidden, secret, or not visible to the naked eye. It refers to signs, symptoms, or conditions present in the body but not visible through a standard physical examination or simple observation; they must be detected using special tests or laboratory equipment.
Obligate: Because they cannot generate sufficient energy on their own, obligate intracellular pathogens act as "energy parasites" that hijack the host cell's resources.
Intracellular: aka "inside a cell." In infectious diseases, an intracellular pathogen is a microorganism (such as a virus, bacterium, fungus, or parasite) that enters, survives, and multiplies inside a host’s cells rather than living in the bloodstream or fluid spaces between cells.
Pathogen: In medical terms, a pathogen is any biological agent—such as a virus, bacterium, fungus, protozoan, or prion—that can enter a host organism and cause disease. Bacteria are most associated with chronic diseases currently,
Intracellular bacteria invade your cells and rob energy from mitochondria.
QUESTION TO OPENEVIDENCE AI: What is the diagnostic difference between IgG and IgM? Many doctors assume IgG is historical.
But it is relatively unknown that occult obligate intracellular pathogens exist in 3 different life forms. Here is an excerpt from the work of Charles Stratton:
"Chlamydiae are obligate intracellular microorganisms which parasitize eukaryotic cells and are ubiquitous throughout the animal kingdom. Members of the chlamydial genus are considered bacteria with a unique biphasic developmental cycle having distinct morphological and functional forms. This developmental growth cycle alternates between
1) intracellular life forms, of which two are currently recognized: a metabolically active, replicating organism known as the reticulate body (RB) and
2) a persistent, non-replicating organism known as the cryptic phase; and
3) an extracellular life form that is an infectious, metabolically inactive form known as the elementary body (EB)." (Reference: https://patents.google.com/patent/US6579854B1/en)
The point is that different types of antibodies are produced in our body in response to these 3 life forms of these stealth organisms.
IgM generally marks a recent or primary immune response, while IgG appears later and can stay detectable for months to years.
An IgG result alone shows exposure.
It does not mean the infection is gone (Few infectious disease and/or functional doctors understand this!) and
it does not prove the infection is still active either. [1-2] (However, the organisms can shift between life forms and become active again!)
For chlamydiae, the point about persistence is fair: standard IgG titers cannot tell past immunity apart from persistent infection. [3] But the reverse also holds. A positive IgG cannot be read as proof of an ongoing cryptic or persistent infection, because antibodies can last long after the organism is cleared. [4-5] See the box below.
How the two isotypes (IgG and IgM) work as markers
IgM: Made first after a primary infection. In chlamydial (or other obligate intracellular) infection, it appears about 2–3 weeks after onset. Its limitations: [6]
False positives from cross-reactivity, including between Chlamydia species. [2][6] - You should not be concerned about false positives for a single organism because infected people often have many different organisms that take advantage of the fact that you were initially susceptible to one species.
Often missing in reinfection, and blunted by early antibiotics or immunosuppression. [2][6]
For rickettsiae, the CDC specifically warns that IgM has poor specificity and should not be used alone. [7] (Many organisms have "poor specificity" with current tests. If a test is positive, you HAVE SOMETHING of this ilk, but we just don't know what. Treatment often works across multiple organisms of this type!)
IgG: Rises later and stays up. Single high titers are hard to interpret:
For C. pneumoniae, a single IgG titer of 512 or higher should be read with caution, because high titers can persist for years without disease. Titers of 16–256 suggest past infection. [8] (Most of this statement is wrong. The organisms can be stealthy and not detected by the WBC test. If the titer is elevated, if it is NOT active now, it WILL BE in the future without improving your terrain or treating it through immune support.)
About 5–10% of the US population has R. rickettsii IgG at a titer of 64 or higher. [7] Eighty percent of people 60 years or older are positive for chlamydia pneumoniae. It's silently active in most, if not all of these people and is a significant driver of diseases of aging.
What actually shows active infection: A fourfold rise in titer between paired acute and convalescent sera is far more informative than either isotype on a single sample. IgG avidity testing can separate recent infection (low avidity) from older infection (high avidity). [2][7-8]
Persistence and what serology can show
The persistent (cryptic) state in the Stratton excerpt matches the accepted concept of persistent chlamydial infection. In this state, viable organisms are present inside cells but cannot be cultured. In vitro, it can be triggered by interferon-γ, iron deprivation, amino acid starvation, or penicillin. [3]
Ongoing antigen exposure during prolonged infection does drive higher IgG titers. High anti-chlamydial IgG is linked to repeated or prolonged infection and worse immune control. That is a population-level association. It is not a diagnostic test for an individual patient. [9]
Research into persistence-specific antigens (for example TroA and HtrA, which are differently expressed during persistence) is aimed at exactly this gap. These are investigational, not validated clinical assays. [3]
Guidelines rate chlamydial serology as having no value for uncomplicated lower urogenital infection and limited value for ascending infection or infertility work-up. It also cannot be used to monitor treatment, because antibodies persist after cure. [4-5]
Practical interpretation
Active infection is diagnosed by finding the organism: NAAT or PCR on the right specimen, including tissue when deep or persistent infection is suspected. RNA-based assays such as TMA reflect viable, metabolically active organisms better than DNA-based tests do. [3][5][10]
Expert bodies do not support treating based on IgG alone, including long antibiotic courses for presumed cryptic infection. [10]
Situations where serology helps: IgM for neonatal C. trachomatis pneumonia (MIF IgM titer of 32 or higher); high IgG titers in LGV (MIF IgG titer of 128 or higher); and paired sera or IgM criteria for acute C. pneumoniae. [4][8]
The idea behind the patent (https://patents.google.com/patent/US6579854B1/en) (persistent forms not detected by routine methods) is biologically plausible. However, no validated serologic marker currently identifies cryptic-phase infection in an individual patient, so neither "IgG = historic" nor "IgG = occult active infection" is a supportable diagnostic rule, but cannot be dismissed, as treating "self" entities like LDL have proven unsuccessful at improving health.
Relevant Images:
Answer: Run the CBC with a differential test and examine the various immune cell counts. A subtle change from "optimal" suggests active infection with these types of organisms, with a fair degree of certainty. This tool is neglected in all studies looking at occult obligate intracellular pathogens as root-cause agents! If the total WBC is not very close to 4.5 x10E3/uL.
Proposed resolution of serological ambiguity through determination of avidity (functional affinity).
A, Possible serological immunoglobulin M (IgM)/IgG constellations following primary viral infection are schematically summarized. In serological practice, the “text book constellation” with IgM seroconversion preceding IgG seroconversion (a) is rather rare.
Parallel determination of IgM and IgG usually represents the most frequent case (b).
Delayed occurrence of IgM is less frequent (c).
In several cases of acute infections, the detection of the IgM may be missed (d).
This may be due to low expression of IgM response, problems of sensitivity of the assay used, competition of IgM by IgG during the assay or missing the right time point of positivity of the response.
In few cases, IgM responses may persist for longer times after primary infection (e).
B, The inclusion of IgG avidity allows an unambiguous determination of early, intermediate, and past infection, irrespective of the variability of the IgM response. The diagnostic power of avidity determination has been shown for many viral systems.




Development cycle - different life forms of the occult obligate intracellular pathogens.
References:
§§1.§§Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing.§§Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024. Hayden MK, El Mikati IK, Hanson KE, et al.Guideline§§2.§§The Significance of Antigen-Antibody-Binding Avidity in Clinical Diagnosis.§§Critical Reviews in Clinical Laboratory Sciences. 2025. Li Y, Yang HS, Klasse PJ, Zhao Z.Review§§3.§§Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.§§European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 2017. Hokynar K, Korhonen S, Norja P, Paavonen J, Puolakkainen M.§§4.§§Background review for the ‘2015 European guideline on the management of Chlamydia trachomatis infections’.§§International Journal of STD & AIDS. 2015. Lanjouw E, Ouburg S, de Vries HJ, et al.Review§§5.§§Laboratory detection methods for Chlamydia trachomatis infection in children: a review.§§European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 2026. Sun Y, Dong S, Zhou Q.RecentReview§§6.§§Chlamydia pneumoniae.§§Red Book: 2024–2027 Report of the Committee on Infectious Diseases. 2024. Committee on Infectious Diseases, American Academy of Pediatrics§§7.§§Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States.§§MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 2016. Biggs HM, Behravesh CB, Bradley KK, et al.Guideline§§8.§§ChlamydiaceaeThis chapter contains material presented in chapter 63 by James B. Mahony, Brian K. Coombes, and Max A. Chernesky in the eighth edition of this Manual.§§Manual of Clinical Microbiology 10th Edition. 2011. Charlotte Gaydos, Andreas Essig§§9.§§Anti‐chlamydia IgG and IgA are insufficient to prevent endometrial chlamydia infection in women, and increased anti‐chlamydia IgG is associated with enhanced risk for incident infection.§§American Journal of Reproductive Immunology. 2019. Darville T, Albritton HL, Zhong W, et al.§§10.§§Integrated laboratory protocol for the diagnosis of Sexually Transmitted Infections (STIs): Standardized pre-analytical procedures, rapid screening, hemagglutination, and ELISA methods for use in resource-limited settings.§§PloS One. 2025. Ramamonjiarisoa FM, Razafiarimanga ZN, Ramaroson R.Recent§§11.§§The variability of the serological response to SARS‐corona virus‐2: Potential resolution of ambiguity through determination of avidity (functional affinity).§§Journal of Medical Virology. 2021. Bauer G.Review§§12.§§Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.§§Molecular Microbiology. 2011. Saka HA, Thompson JW, Chen YS, et al.§§13.§§Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle.§§Molecular Microbiology. 2000. Shaw EI, Dooley CA, Fischer ER, et al.§§


Stay Connected
Get low- or no-cost health tips, root-cause solutions, or a health audit.
Need Support?
Call us at: 202.630.3221
Email us at: frugaldr@gmail.com
Use the form on the right to share your wants/needs.
FrugalDoc
Affordable Health & Wellness
© 2025 FrugalDoc Health & Wellness. All rights reserved.
